Kronos Bio, Inc. (KRON) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Kronos Bio, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
Kronos Bio, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 32 %, a 54.8% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	32	+11.3	+54.8%	Mar 31, 2024
Q4 2023	30.6	+12.9	+72.9%	Dec 31, 2023
Q3 2023	27.1	+11.2	+70.2%	Sep 30, 2023
Q2 2023	23.5	+9.26	+65%	Jun 30, 2023
Q1 2023	20.7	+7.78	+60.4%	Mar 31, 2023
Q4 2022	17.7	+6.2	+54%	Dec 31, 2022
Q3 2022	15.9	+5.2	+48.7%	Sep 30, 2022
Q2 2022	14.2	-13.8	-49.2%	Jun 30, 2022
Q1 2022	12.9			Mar 31, 2022
Q4 2021	11.5			Dec 31, 2021
Q3 2021	10.7			Sep 30, 2021
Q2 2021	28			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.